The Boardroom and the Cleanroom
In two days at Purdue, two rooms that shared no agenda gave the same answer about AI. Neither was about the tools.
Good AI's newsletter
Exploring the intersection of AI, Healthcare, Fintech, ESG, Venture Capital and Entrepreneurship
Live Last read · last published · next check
Latest posts
The Guardrail Only Bound One Side
What three weeks in July told us about where AI value actually settles.
The $0.50 Barrel of Intelligence
Token prices are collapsing, the anger in corporate America is real, and the money is moving to the layer that decides which model to trust.
The Week the Frontier Went Two Directions at Once
China's GLM-5.2, Anthropic's Fable shutdown, and why neither the closed model nor the open one solves the thing that actually matters.
Cerebras Couldn't Exist Without TSMC
A constraint-layer reading of the $95B IPO — and why the foundry partnership matters more than the wafer
The Claude Code Leak: What It Reveals About Where AI Value Actually Lives
Anthropic accidentally gave the market a blueprint. A developer rebuilt it overnight in Python. And a prominent venture investor just identified the sharpest contradiction in AI investing today.
OpenAI Acquired OpenClaw: Why Workflow Infrastructure Is Where the Value Is Migrating
On February 15, 2026, Sam Altman announced that OpenAI had acquired OpenClaw and that Peter Steinberger was joining the company.
NVIDIA × Groq: Why the Inference War Forced a $20B Decision
Before getting into strategy, silicon, or deal mechanics, it’s worth starting with a round of congratulations.
Aether’s Inflection Point: Congratulations on the $15M Raise — and the Dawn of Molecular Manufacturing
I want to begin by extending my warmest congratulations to Aether Biomachines on its newly announced $15 million Series A1 financing.
Honoring Bill Young: From the Origins of Insulin to the Future of Biomanufacturing
Insulin is not a cure for diabetes; it is a treatment.